Award of Contracts without Competition December 2013
|
|
|
- Crystal Payne
- 5 years ago
- Views:
Transcription
1 SERIVCES 2850 Open Text Opentext Web CMS Software Support 125, Business Services Organisation 2259 Lynas Cooked Pork (Lynas) 63, Limavady Office Products 169, Merck no 3 Nutritional Services Consumables 57, Covidien no 3 Nutritional Services Consumables 90, Genesys Medical no 3 Nutritional Services Consumables 175, Nutricia Nutritional Services Consumables 265, ABBOTT LABORATORIES Generic Medicines 34, MERCK SHARP DOHME Generic Medicines 35, RANBAXY Generic Medicines 39,768.00
2 2971 MERCK SERONO UK LTD Generic Medicines 47, KENT PHARMACEUTICALS Generic Medicines 53, ZENTIVA Generic Medicines 55, FRESENIUS KABI Generic Medicines 58, PECKFORTON Generic Medicines 58, ZENTIVA Generic Medicines 64, JANSSEN CILAG Generic Medicines 66, BAXTER Generic Medicines 66, UCB PHARMA LTD Generic Medicines 66, TRINITY-CHIESI 2986 PHARMACEUTICALS LTD Generic Medicines 68,683.00
3 2918 ACTAVIS Generic Medicines 70, FOCUS Generic Medicines 74, TEVA UK LTD Generic Medicines 75, ALLIANCE PHARMACEUTICALS Generic Medicines 76, AMDIPHARM Generic Medicines 88, BOWMED IBISQUS Generic Medicines 92, SANDOZ Generic Medicines 94, BRAUN MEDICAL Generic Medicines 92, MARTINDALE PHARMA Generic Medicines 99, ROSEMONT 2981 PHARMACEUTICALS Generic Medicines 108,481.00
4 HAMELN PHARMACEUTICALS 2966 LTD Generic Medicines 137, ROCHE Generic Medicines 139, SANDOZ Generic Medicines 140, MYLAN Generic Medicines 161, MERCK SERONO Generic Medicines 57, TRUST 2275 Hospital Services Ltd X-Ray Equipment Maintenance Contract 50, TRUST S1006 Boehringer Ingelheim BOEHRINGER S , TRUST S1007 Gilead Sciences Ltd GILEAD SCIENCES S , TRUST S1014 Movianto Ireland Movianto Ireland) S , TRUST S1002 AAH Pharmaceuticals AAH) S ,960.00
5 TRUST S1017 UDG Ltd UDG Ltd S , TRUST S1015 Novartis Novartis S , TRUST S1012 UDG Ltd UDG Ltd S , TRUST S1008 Healthcare at Home HEALTHCARE AT HOME S , TRUST S1019 AAH Pharmaceuticals AAH S , TRUST S1011 Sangers N.I. Sangers N.I. S , TRUST S1003 AAH Pharmaceuticals AAH S , TRUST S1009 Movianto Ireland Movianto Ireland S , HEALTH AND SOCIAL CARE BOARD 2366 British Telecom Rental and Maintenance of Telephone System 520,000.00
6 HEALTH AND SOCIAL CARE Rental and Maintenance of Telephone 2367 Virgin Media BOARD System 72, SOUTH EASTERN HSC TRUST SET04 9/1310 SOUTH EASTERN HSC TRUST 2514 AAH Alteplase 50mg vials 78,000 Medilink Services Maintenance of monitors and pulse oximeters at Ulster Community and Hospitals Trust (increase) 38, SOUTH EASTERN HSC TRUST SET05 1/1310 Sangers distribution Klerwipe - Klercide, Klerclean and Klerwipe aseptic disinfectant system 42,000 SAFEGUARDING BOARD NI 3009 John Pinkerton CSE Thematic Review NORTHERN IRELAND FIRE AND RESCUE SERVICE 2390 NORTHGATE INFORMATION SOLUTIONS SUPPORT FOR MIS INFRASTRUCTURE 71, Social Care Trust 2823 Bioptigen Bioptigen Envisu Portable OCT 50, Social Care Trust 2802 Phillips Social Care Trust STAPM Vertex PACs Storage Solution for RBHSC cardiology IVACAFTOR 150 mg Tablets 75, ,674,
7 STAPM AFLIBERCEPT INTRAVITREAL 40 mg in Social Care Trust Bayer 1mL Injection 02 53, Social Care Trust 2729 Covidien Covidien Vnus Closure Catheters 51,625.00
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES PUBLISHED AUGUST 2016 There is growing distrust of pharma in light of several recent and dramatic
Medicines availability short-term supply issues Last updated 01/05/18
Short-term supply issues This resource includes availability information on medicines that are reported to have supply issues, with next expected availability within the next three months. This list is
Quality of medicines in Portugal: a retrospective review of medicine recalls ( ) Ana Teresa Reis Bruna Berardo Rui Loureiro
Quality of medicines in Portugal: a retrospective review of medicine recalls (2005-2015) Ana Teresa Reis Bruna Berardo Rui Loureiro Introduction Human medicines Cosmetics Veterinary medicines Medical devices
Respiratory Research Newsletter
Date Published: September 2012 Respiratory Research Newsletter Contents Research at the Belfast Trust 1 NICRN Respiratory Health 2 The Respiratory Research Team 3 Our Partners 4 Getting Involved in Upcoming
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal Review of TA114 Methadone and buprenorphine for the management of
75th AAD Annual Meeting
75th AAD Annual Meeting Poster nº 4873 A phase 3 randomized, double-blind, trial comparing the efficacy and safety of the fixed combination calcipotriene 0.005% (Cal) and betamethasone dipropionate 0.064%
Single Technology Appraisal (STA) Adalimumab for treating moderate to severe hidradenitis suppurativa
Single Technology Appraisal (STA) Adalimumab for treating moderate to severe Comment 1: the draft remit Response to consultee and commentator comments on the draft remit and draft scope (pre-referral)
Kenneth Gordon, 1 Kim A. Papp, 2 Kara Creamer Rice, 3 Mona Trivedi, 3 David H. Collier, 3 Greg Kricorian 3
American Academy of Dermatology 75 th Annual Meeting, Orlando, FL; March 3 7, 2017 Poster 4563 Novel Evaluation of Psoriasis Area and Severity Index (PASI) Data: Distribution of PASI Improvements in a
REGULATORY UPDATES: APPROVAL, DENIALS AND AGREEMENTS REGULATORY UPDATES: APPROVAL, (CONTINUED)... 38
CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED
Generic and originator immunosuppressants - comparative list prices and bioequivalence data
Ciclosporin Neoral (Novartis) Capimune (Mylan) NHS Net price (as per the BNF) Date: November 2016 Bioequivalence assessment vs. originator 10mg capsule, 60= 18.25 25mg capsule, 30= 18.37 50mg capsule,
US pharmaceutical market: trends, issues, forecast. Doug Long Vice President Industry Relations IMS Health
US pharmaceutical market: trends, issues, forecast Doug Long Vice President Industry Relations IMS Health 2006 Strategic management review The World Pharmaceutical Market All reproduction rights, quotations,
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Review proposal of NICE guidance no. 82; on the use of pimecrolimus and tacrolimus for atopic eczema Provisional matrix
Report to the Board of Directors April Annual Gifts and Hospitality Report for the period 1st April st March 2014
Report to the Board of Directors April 2014 Annual Gifts and Hospitality Report for the period 1st April 2013 31st March 2014 The Trust s policy on the Receipt of Hospitality, Gifts, Payment and Commercial
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Review Proposal of NICE Technology Appraisal no. 81; on the frequency of application of topical Provisional matrix of consultees
Male Female Both sexes Male Female Both sexes. Male Female Both sexes Male Female Both sexes 9.8% 11.1% 10.3% 1,057 1,002 2,059
LUNG CANCER NUMBER OF CASES PER YEAR (2011-2015) NUMBER OF DEATHS PER YEAR (2011-2015) Male Female Both sexes Male Female Both sexes 667 543 1,210 1 546 412 957 1 FIVE-YEAR SURVIVAL (2005-2009) 23-YEAR
Ovarian Cancer Guideline. Association of Chartered Physiotherapists in Oncology and Palliative Care
Ovarian Cancer Guideline Stakeholder List: A Little Wish Abbott GmbH & Co KG Abbott Laboratories Limited Aberdeen Royal Infirmary Airedale NHS Foundation Trust Almac Diagnostics Anglia cancer network Arden
Children and young people with cancer (quality standard) Stakeholder Abbott Molecular Action for Sick Children Acupuncture Association of Chartered
Children and young people with cancer (quality standard) Stakeholder Abbott Molecular Action for Sick Children Acupuncture Association of Chartered Physiotherapists Alder Hey Children's NHS Foundation
Patient Interest Groups Submission of Evidence Template. Version 1.1. Drug Name: _MAVENCLAD (Cladribine tablets) Date of Submission to NCPE:
Patient Interest Groups Submission of Version 1.1 Drug Name: _MAVENCLAD (Cladribine tablets) Date of Submission to NCPE: Record of Updates Version Date Description of changes 1.0 01.05.2014 N/A 1.1 26.07.2016
Systemic and inhaled fluoroquinolones: risk of aortic aneurysm and dissection
Direct Healthcare Professional Communication 23 rd October 2018 Systemic and inhaled fluoroquinolones: risk of aortic aneurysm and dissection Dear Healthcare Professional, The Marketing Authorisation Holders
INTRAVENOUS (IV) THERAPY AND VEIN ACCESS: GLOBAL MARKETS
INTRAVENOUS (IV) THERAPY AND VEIN ACCESS: GLOBAL MARKETS HLC046C November 2014 Mary C. Patton Project Analyst ISBN: 1-56965-982-6 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215
Medicines availability long-term supply issues Last updated 10/04/18
Long-term supply issues This resource includes availability information on medicines that are reported to have supply issues, with next expected availability greater than three months or no known date.
SickKids Research Institute: List of Funders
SickKids Research Institute: List of Funders 2009-2010 Agency Funding $ Agency Funding $ 3M Pharmaceuticals 2,901 International Council on Amino Acid Science 80,800 Abbott Diagnostics 6,639 International
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Technology Appraisals and Guidance Information Services Static List Review (SLR) report Title and TA publication number of static topic: Final decision:
GLOBAL MARKETS FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES
GLOBAL MARKETS FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES PHM005C January 2013 Peggy Lehr Project Analyst ISBN: 0-89336-646-3 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481
SAMPLE. Asia-Pacific Drug Delivery Devices Market Outlook to Metered Dose Inhaler Devices, Infusion Systems, Central Venous
Asia-Pacific Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others Reference Code: GDME0220RDB Publication Date: January 2013
Information for Vermont Prescribers of Prescription Drugs Tradjenta (linagliptin) and Jentadueto (linagliptin+metformin) Tablets
Information for Vermont Prescribers of Prescription Drugs Tradjenta (linagliptin) and Jentadueto (linagliptin+metformin) Tablets This list does not imply that the products on this chart are interchangeable
BRIC DIABETES DRUGS MARKET
BRIC DIABETES DRUGS MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d M a
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 07/3.1.2.2/23 NOVARTIS SA
1, FIVE-YEAR SURVIVAL ( ) 88.5% 9,347
PROSTATE CANCER NUMBER OF CASES PER YEAR (2011-) NUMBER OF DEATHS PER YEAR (2011-) 1,092 254 FIVE-YEAR SURVIVAL (2005-2009) 23-YEAR PREVALENCE () 88.5% 9,347 INCIDENCE In 2011- there were 1,092 men diagnosed
Male Female Both sexes Male Female Both sexes 10 1,333 1, FIVE-YEAR SURVIVAL ( ) Male Female Both sexes Male Female Both sexes
BREAST CANCER NUMBER OF CASES PER YEAR (2011-2015) NUMBER OF DEATHS PER YEAR (2011-2015) Male Both sexes Male Both sexes 10 1,333 1,343 3 310 313 FIVE-YEAR SURVIVAL (2005-2009) 23-YEAR PREVALENCE (2015)
(Poster presented on Sunday 05 March, 08:50 08:55; 2017 AAD Meeting, Orlando, Florida, USA)
Secukinumab in Psoriasis Patients with Concurrent Psoriatic Arthritis: Patient-Reported Outcomes in the Corrona Psoriasis Registry AB Gottlieb, B Strober, 2 AW Armstrong, 3 JD Greenberg, 4,5 C Karki, 4
List of nationally authorised medicinal products
3 December 2015 EMA/98477/2016 Procedure Management and Committees Support Active substance: acarbose Procedure no.: PSUSA/00000017/201503 30 Churchill Place Canary Wharf London E14 5EU United Kingdom
Information for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs CADUET (amlodipine besylate/atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have
SAMPLE. South and Central America Drug Delivery Devices Market Outlook to Metered Dose Inhaler Devices, Infusion Systems, Central
South and Central America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others Reference Code: GDME0222RDB Publication Date:
Funding Opportunities for Public Health Research
Funding Opportunities for Public Health Research IPH Open Conference,Titanic Belfast, 11 October 2016 Dr Nicola Armstrong Programme Manager HSC R&D Division, Public Health Agency Outline Strategic Context
Oncology Pipeline Analytics
Oncology Pipeline Analytics Trials, Drug Classes, Indications, Correlations and Strategies Report Brochure O n c o l o g y P i p e l i n e A n a l y t i c s Greystone Research Associates is pleased to
Information for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs LIPITOR (atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have the same efficacy or
PBS Growth. The changing composition of the PBS. PBS Top 10 drugs in transition. Shifting sands for industry as generic volume soars
PBS Growth The changing composition of the PBS PBS Top 10 drugs in transition Shifting sands for industry as generic volume soars The under co-payment market PBS Update 2014-15 Growth in PBS spending was
Recommended comparator products: Medicines for HIV/AIDS and related diseases
Recommended comparator products: Medicines for HIV/AIDS and related diseases Comparator products should be purchased from a well regulated market with stringent regulatory authority 1. Invited medicinal
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal Review of TA215; Pazopanib for the first line treatment of advanced
Off-Label / Off-Licence Use of Medicines Drug and Therapeutics Committee Papworth Hospital NHS Trust - June 2012 GREEN
Off-Label / Off-Licence Use of Medicines Drug and Therapeutics Committee Papworth Hospital NHS Trust - June 2012 GREEN Drug Indication Off-label / Licence details Speciality Manufacturer Coding Acetazolamide
LETTERS FOR ISSUE ON
S FOR ISSUE ON 01.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S TYCHE INDUSTRIES LTD., ANDHRA PRADESH, INDIA IMPORT S. NAME OF APPLICANT DIARY TYPE OF 1. PIRAMAL ENTERPRISES LTD. 25471 APPROVAL
Male Female Both sexes Male Female Both sexes 11 1,367 1, FIVE-YEAR SURVIVAL ( ) Male Female Both sexes Male Female Both sexes
BREAST CANCER NUMBER OF DEATHS PER YEAR NUMBER OF CASES PER YEAR (2012-2016) 1 (2012-2016) Male Both sexes Male Both sexes 11 1,367 1,378 3 306 313 FIVE-YEAR SURVIVAL (2006-2010) 24-YEAR PREVALENCE (2016)
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal Review of TA96; Adefovir dipivoxil and peginterferon alfa-2a for
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)
25 June 2010 corr. 1 Press Office Press release Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 June 2010 Positive opinions for new medicines adopted The Committee
International Pharmaceutical Aerosol Consortium on Regulation and Science
International Pharmaceutical Aerosol Consortium on Regulation and Science 1500 K Street NW Washington DC 20005 Telephone +1 202 230 5607 Fax +1 202 842 8465 Email info@ipacrs.org Web www.ipacrs.org Submitted
Case 1:14-cv LPS Document 195 Filed 01/05/16 Page 1 of 5 PageID #: 6023
Case 1:14-cv-00121-LPS Document 195 Filed 01/05/16 Page 1 of 5 PageID #: 6023 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE FOREST LABO RA TORIES, INC., FOREST LABO RA TORIES HOLDINGS,
Male Female Both sexes Male Female Both sexes FIVE-YEAR SURVIVAL ( )
CERVICAL CANCER This document contains statistical information about cervical cancer and carcinoma in situ. Carcinoma in situ can be found during cervical screening tests and is when some of the cells
in patients with diabetes, nephropathy and/or chronic kidney disease Summary of recommendations July 2017
Association of British Clinical Diabetologists (ABCD) and Renal Association clinical guidelines: Hypertension management and reninangiotensin-aldosterone system blockade in patients with diabetes, nephropathy
CONTRACT UPDATE July 20, 2012
CONTRACT UP July 20, 2012 ADDS AMPHETAMINE SALT MIX ER CAPSULE 10MG 100 002-3059-11 $422.45 ACTAVIS ADDS AMPHETAMINE SALT MIX ER CAPSULE 20MG 100 002-3060-11 $422.45 ACTAVIS ADDS AMPHETAMINE SALT MIX ER
Membership of cirrhosis guideline Committee
Membership of cirrhosis guideline Committee The Committee will operate as an advisory Committee to NICE s Board, developing a guideline on cirrhosis. The terms of reference and standing orders for the
DLQI (ESTEEM
192 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients With Moderate to Severe Plaque Psoriasis: Pruritus and DLQI Correlations at Week 16 (ESTEEM 1 and 2) Steven R. Feldman, MD, PhD 1 ; Diamant
Insights from the Kaiser Permanente database
Insights from the Kaiser Permanente database Jashin J. Wu, M.D. Founding Director of Dermatology Research Director, Psoriasis Clinic Department of Dermatology Kaiser Permanente Los Angeles Medical Center
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
MS Trust Comments on the ACD
MS Trust Comments on the ACD Name xxxxxxxxxxx Role other Other role xxxxxxxxxxxxxxxxxx Location England Conflict no Notes Comments on individual sections of the ACD: Section 1 The MS Trust maintains that
Iraq NDI Iraq 04-J India 05-AH France Famar Lyon France 05-D UNITED ARAB EMIRATES. Iraqi Biocon Limited Indian 06-AA0-001
nam origmanufacturer nammanufacturer National code Mousel Scientific Iraq NDI Iraq 04-J00-042 Sandoz GmbH Austria for Sandoz GmbH by Sandoz Ilac Sanayi ve India 05-AH0-040 France Famar Lyon France 05-D00-024
Compare your care. How asthma care in England matches up to standards R E S P I R AT O R Y S O C I E T Y U K
Compare your care How asthma care in England matches up to standards PRIMARY CARE R E S P I R AT O R Y S O C I E T Y U K Asthma matters Around 4.5 million people in England that s 1 in 11 are being treated
Professor Caroline Sabin
Professor Caroline Sabin in partnership with Royal Free & University College Medical School London, UK COMPETING INTEREST OF FINANCIAL VALUE > 1,000 Statement Over the past five years, Caroline Sabin has
Male Female Both sexes Male Female Both sexes FIVE-YEAR SURVIVAL ( )
MALIGNANT MELANOMA NUMBER OF CASES PER YEAR (2011-2015) NUMBER OF DEATHS PER YEAR (2011-2015) Male Female Both sexes Male Female Both sexes 163 194 357 26 21 47 FIVE-YEAR SURVIVAL (2005-2009) 23-YEAR PREVALENCE
MANUFACTURING PROBLEMS AS OF 29th February 2016
MANUFACTURING PROBLEMS AS OF 29th February 2016 Drug Manufacturer Brand Name Comments Amoxycillin powder for Injection 1gram x 10 Amoxycillin powder for Injection 500mg x 10 Amoxycillin & Clavulanic 600mg
REQUEST FOR INFORMATION - HEPATITIS C TREATMENTS
10 August 2015 REQUEST FOR INFORMATION - HEPATITIS C TREATMENTS PHARMAC is seeking information from suppliers of novel direct-acting antiviral agents (DAAs) for the treatment of hepatitis C. This Request
NHS Pharmaceutical Quality Assurance Service Safe Medication Bulletin
NHS Pharmaceutical Quality Assurance Service Safe Medication Bulletin Divisional Contracts Wave 8b 33% (DCE and DSW) This Bulletin alerts users to products accepted for the National Contracts which have
Evidence grades for the recommendations
Association of British Clinical Diabetologists (ABCD) and Renal Association clinical guidelines: Hypertension management and renin-angiotensin-aldosterone system blockade in patients with diabetes, nephropathy
nephropathy and/or chronic kidney disease Summary of recommendations
July 2017 Guidelines: Association of British Clinical Diabetologists (ABCD) and Renal Association clinical guidelines: Hypertension management and reninangiotensin-aldosterone system blockade in patients
Exhibitor Prospectus
+ National Meeting and Expo 2018 Exhibitor Prospectus The 2018 Innovatix + Essensa National Meeting & Expo is the only event that provides access to Innovatix and Essensa s most engaged and active members,
A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database
A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database Contract Research Organization / Terzetto Pharma Metrics NIVETHA CHELLAPATHY
October 2008 changes in Multilex Drug Dictionary
October 2008 changes in Multilex Drug Dictionary Summary of Changes In the October 2008 Multilex Drug Dictionary, there are behind-the-scenes changes which may require you to reauthorise. The drugs involved
UKALL14 DRUG SUPPLY GUIDELINES
CONTACT DETAILS UKALL14 DRUG SUPPLY GUIDELINES For further information on trial drugs, trial protocol, dosing, supply drug and distribution queries please contact: UKALL14 Trial Team Phone: 0207 679 9860
LETTERS FOR ISSUE ON
S FOR ISSUE ON 27.08.2015 NEW DRUG S. NAME OF APPLICANT DIARY TYPE OF 1. M/S. INTAS PHARMACEUTICALS LIMITED - CT NOC (2) 2. M/S. PFIZER LIMITED - QUERY 3. M/S. MSN LABORATORIES - ADDITIONAL SITE 4. M/S.
THINC-it: what is it? John Harrison Alzheimer Center, VU University Medical Center, West London Mental Health Trust, Metis Cognition Ltd
THINC-it: what is it? John Harrison Alzheimer Center, VU University Medical Center, West London Mental Health Trust, Metis Cognition Ltd Disclosures Associate Professor in the Alzheimer Center at the VU
PRAC recommendations on signals
3 April 2018 1 EMA/PRAC/136563/2018 Pharmacovigilance Risk Assessment Committee (PRAC) Adopted at the 5-8 March 2018 PRAC meeting This document provides an overview of the recommendations adopted by the
Paediatric Dentistry Referral Guidelines
Paediatric Dentistry Referral Guidelines The Paediatric Dental Department can only accept referrals for children under the age of 13 years. These guidelines are intended to assist General Dental Practitioners
New Tube Feeding Connectors. June 24, 2014
New Tube Feeding Connectors June 24, 2014 Learning Objectives 1. Explain why new tube feeding connectors are needed at home 2. Outline timeline & transition plan for new connectors 3. Hands on experience
Early and locally advanced Breast cancer (review) Stakeholders
Early and locally advanced Breast cancer (review) Stakeholders Abbott Laboratories Abbott Molecular Abraxis Oncology Afiya Trust Age UK Airedale NHS Trust All About Nocturnal Enuresis Team Almac Diagnostics
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal Review of TA 118 Colorectal cancer (metastatic) - bevacizumab &
HEPATITIS B: WHO AND WHEN TO TREAT?
HEPATITIS B: WHO AND WHEN TO TREAT? George V. Papatheodoridis Professor in Medicine & Gastroenterology Medical School of National & Kapodistrian University of Athens Director of Academic Department of
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) A05/11.5/08 A38/20.1.1/0406
CHAPTER ONE: EXECUTIVE SUMMARY
CHAPTER ONE: EXECUTIVE SUMMARY Introduction Scope and Methodology Total Size and Growth of the Market Issues and Trends Affecting Market Leading Competitors CHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDS
NHS LOTHIAN JANUARY PAYMENTS OVER 25,000 Payments through Accounts Payable Balance sheet
NHS LOTHIAN JANUARY PAYMENTS OVER 25,000 Payments through Accounts Payable Balance sheet L3 CC Name Date Paid Supplier Name Amount Narrative Balance Sheet 04/01/2013 National Procurement 1,588,757.16 Monthly
CHAPTER ONE: EXECUTIVE SUMMARY
CHAPTER ONE: EXECUTIVE SUMMARY Introduction Scope and Methodology Size and Growth of the Market Issues and trends Leading Competitors CHAPTER TWO: INTRODUCTION AND OVERVIEW Definition of Pain Magnitude
RightBreathe to help with inhaler prescribing and technique
www.rightbreathe.com RightBreathe to help with inhaler prescribing and technique Dr Azhar Saleem GP Respiratory Lead, Lambeth CCG GP Specialist NHS London Procurement Partnership Clinical Lead RightBreathe
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 36/20.1.2/0204 BIOTECH 36/20.1.2/0205
Medical Device Alert. Device Non CE-marked portable dental X-ray units. Including the Tianjie Dental Falcon. Action by
Medical Device Alert Issued: 16 July 2012 at 15:30 Device Non CE-marked portable dental X-ray units. Including the Tianjie Dental Falcon. Problem Testing by the Health Protection Agency (HPA) has revealed
List of nationally authorised medicinal products
5 November 2015 EMA/230130/2016 Procedure Management and Committees Support Active substance: cabergoline Procedure no.: PSUSA/00000477/201503 30 Churchill Place Canary Wharf London E14 5EU United Kingdom
Yorkshire & Humber Respiratory Programme Report
2013 NHS Harrogate & Rural District Clinical Commissioning Group Yorkshire & Humber Respiratory Programme Report This report has been produced by the Yorkshire & Humber Respiratory Team. It highlights
ANESTHESIA AND RESPIRATORY DEVICES: GLOBAL MARKETS. HLC167A February Vijay Laxmi Project Analyst ISBN:
ANESTHESIA AND RESPIRATORY DEVICES: GLOBAL MARKETS HLC167A February 2014 Vijay Laxmi Project Analyst ISBN: 1-56965-704-1 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 866-285-7215, 781-489-7301
The Role of EPAG in Standards and Regulatory Guidance Development
The Role of EPAG in Standards and Regulatory Guidance Development Jolyon P. Mitchell on behalf of EPAG Session 4: The Remit, Activities and Achievements of The European Pharmaceutical Aerosols Group 1
Interferon free HCV Therapy: Are we getting there?
Interferon free HCV Therapy: Are we getting there? Heiner Wedemeyer Hannover Medical School Germany 1 Disclosures Honoraria for consulting or speaking (last 5 years): Abbott, Biolex, BMS, Boehringer Ingelheim,
PRAC recommendations on signals
3 October 2013 EMA/PRAC/550442/2013 Pharmacovigilance Risk Assessment Committee Adopted at the PRAC meeting of 2-5 September 2013 This document provides an overview of the recommendations adopted by the
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 47/26/0920 SANOFI-AVENTIS
Guinea pig model of pre-existing vascular disease: Systemic blood pressure and enos response to fresh (F-RBCs) and stored (S-RBCs) RBC transfusion
Supplemental Results Guinea pig model of pre-existing vascular disease: Systemic blood pressure and enos response to fresh (F-RBCs) and stored (S-RBCs) RBC transfusion In the present model HFSD guinea
Bruce Strober 1, 2, Chitra Karki 3, Marc Mason 3, Ning Guo 3, Jeffrey D Greenberg 3,4, Mark Lebwohl 5
Characterization of Disease Burden, Comorbidities and Use of Patients with Psoriasis at Enrollment: Results from the Corrona Psoriasis Registry Bruce Strober 1, 2, Chitra Karki 3, Marc Mason 3, Ning Guo
Childminding as a profession. A guide to registration
Childminding as a profession A guide to registration Childminding as a profession Earn a living by caring for other people s children in your own home. 2 If you enjoy working with children and can provide
CHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW...
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE OF REPORT... 1 MARKET ANALYSES AND FORECASTS... 2 INTENDED AUDIENCE... 2 INFORMATION SOURCES... 2 ANALYST
Medicines availability
The resource includes availability information on medicines that are reported to have supply issues, with next expected availability. Medicines are listed alphabetically by generic name, with a br name
Cost per Responder of Apremilast Versus Etanercept, Adalimumab, and Ustekinumab in Patients With Moderate to Severe Psoriasis
1108 Cost per Responder of Apremilast Versus Etanercept, Adalimumab, and Ustekinumab in Patients With Moderate to Severe Psoriasis Steven R. Feldman, MD, PhD 1 ; Tom Tencer, PhD 2 ; Zoe Clancy, PharmD,
Barr Laboratories, Inc. et al.; Withdrawal of Approval of 68 Abbreviated New Drug Applications
This document is scheduled to be published in the Federal Register on 12/01/2017 and available online at https://federalregister.gov/d/2017-25920, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN
Adherence to therapy. Kamlesh Khunti University of Leicester, UK. William Polonsky University of California San Diego, USA
Adherence to therapy Kamlesh Khunti University of Leicester, UK William Polonsky University of California San Diego, USA 1 Dualities of interest Kamlesh Khunti: Honoraria for speaking, advising or research
Medicines availability
The resource includes availability information on medicines that are reported to have supply issues, with next expected availability. Medicines are listed alphabetically by generic name, with a br name